Serifoglu I,Sen N. Lung,Cancer N. Lung .2023 .Emergencies. , : 1-51.
Rapoport BL,Cooksley T,Johnson DB,Anderson R,Shannon VR .2021 .Treatment of infections in cancer patients: an update from the neutropenia, infection and myelosuppression study group of the Multinational Association for Supportive Care in Cancer (MASCC). Expert review of clinical pharmacology. , 14(3) : 295-313.
Lyman GH,Kuderer NM,Aapro M. . .Improving outcomes of chemotherapy: established and novel options for myeloprotection in the COVID-19 era. , : .
Lantuejoul S,Fernandez-Cuesta L,Damiola F,Girard N,McLeer A .2020 .New molecular classification of large cell neuroendocrine carcinoma and small cell lung carcinoma with potential therapeutic impacts. Translational Lung Cancer Research, 9(5) : 2233.
Lazarus DR,Strange CD,Ahuja J,Shroff GS,Sabloff BS,de Groot PM .2023 .Non-Small Cell Carcinoma. , : 311-72.
.2021 .New insight into the mechanism of granulocyte colony-stimulating factor (G-CSF) that induces the mobilization of neutrophils. Hematology, 26(1) : 628-36.
Suzuki K,Yamada M,Kurakake S,Okamura N,Yamaya K,Liu Q .2000 .Circulating cytokines and hormones with immunosuppressive but neutrophil-priming potentials rise after endurance exercise in humans. European journal of applied physiology, 81 : 281-7.
Hobbs J,Lowe J,Ferdinand A,Shook A,Beck B,Blais D .2023 .Efficacy of same-day versus next-day administration of pegfilgrastim for the prevention of chemotherapy-induced febrile neutropenia in breast cancer patients receiving dose-dense doxorubicin and cyclophosphamide: A retrospective multi-site analysis. Journal of Oncology Pharmacy Practice, 29(8) : 1853-61.
Clemons M,Fergusson D,Joy AA,Thavorn K,Meza-Junco J,Hiller JP .2021 .A multi-centre study comparing granulocyte-colony stimulating factors to antibiotics for primary prophylaxis of docetaxel-cyclophosphamide induced febrile neutropenia. The Breast, 58 : 42-9.
Lazarus HM,Ragsdale CE,Gale RP,Lyman GH .2021 .Sargramostim (rhu GM-CSF) as cancer therapy (systematic review) and an immunomodulator. A drug before its time? Frontiers in immunology. , 12 : 706186.
Li N,Huang C,Zhang J,Zhang J,Huang J,Li S .2023 .Chemotactic NO/H2S nanomotors realizing cardiac targeting of G-CSF against myocardial ischemia-reperfusion injury. ACS nano, 17(13) : 12573-93.
Clemons M,Fergusson D,Simos D,Mates M,Robinson A,Califaretti N .2020 .A multicentre, randomised trial comparing schedules of G-CSF (filgrastim) administration for primary prophylaxis of chemotherapy-induced febrile neutropenia in early stage breast cancer. Annals of Oncology, 31(7) : 951-7.
Najafi S,Ansari M,Kaveh V,Haghighat S. Comparing .2021 .the efficacy and side-effects of PDLASTA®(Pegfilgrastim) with PDGRASTIM®(Filgrastim) in breast cancer patients: a non-inferiority randomized clinical trial. BMC cancer, 21 : 1-12.
Jam F. A.,Singh S. K. G.,Ng B.,Aziz N. .2018 .The interactive effect of uncertainty avoidance cultural values and leadership styles on open service innovation: A look at malaysian healthcare sector. International Journal of Business and Administrative Studies, 4(5) : 208-223.
Kanval N.,Ihsan H.,Irum S.,Ambreen I. .2024 .Human Capital Formation, Foreign Direct Investment Inflows, and Economic Growth: A Way Forward to Achieve Sustainable Development. Journal of Management Practices, Humanities and Social Sciences, 8(3) : 48-61.